PeriSorb® fully degradable peripheral vascular stent completes the first FIM trial enrollment

This is the world's first 3D printed fully degradable peripheral stent implanted in the human body, marking that my country's 3D printing fully degradable peripheral stent with completely independent intellectual property rights has taken the lead in entering the clinical trial stage, and it also marks that my country's 3D printing technology has advanced to the world's leading level. A big step.

2021

12-25

Beijing adds 1,150 municipal-level "specialized, special and new" small and medium-sized enterprises

On December 1, the Beijing Economic and Information Bureau announced the list of the second to seventh batch of "specialized, special and new" small and medium-sized enterprises in Beijing in 2021. The list includes 1,150 small and medium-sized enterprises including Labtech, Digital Video, Geling Shentong, Moji Fengyun Technology, etc.

2021

12-03

Beijing Amet was recognized as a "specialized, special and new" enterprise

On December 1, 2021, the Beijing Municipal Bureau of Economy and Information issued an announcement on the seventh batch of "specialized, refined, and new" small and medium-sized enterprises in 2021. The announcement announced that Beijing Amet Medical Equipment Co., Ltd. was recognized as a "specialized, refined and new" enterprise. This event marks that Amet, as an innovative enterprise, has reached a high level in terms of scientific research strength, technical level and influence, and has been recognized by the competent government departments.

2021

12-02

Professor Antonio Meeks was elected as a foreign academician of the Chinese Academy of Engineering

According to the announcement issued by the Chinese Academy of Engineering today, the 2021 academician co-election of the Chinese Academy of Engineering has been completed recently, and a total of 84 academicians of the Chinese Academy of Engineering and 20 foreign academicians of the Chinese Academy of Engineering have been elected. Professor Antonio Meeks was elected as a foreign academician of the Chinese Academy of Engineering

2021

11-18

Beijing Amet Company successfully obtained 2 national trademark registration certificates

Recently, our company applied for registration of the trademarks "Amet PERISORB" and "PERISORB", and successfully obtained the trademark certificate issued by the State Intellectual Property Office. These two trademarks will be mainly used for the fully degradable peripheral vascular drug-eluting stent system products developed by our company using independent innovative 3D printing technology.

2021

11-16

Beijing Amet's patent application was authorized by the European Patent Office

Recently, the European patent application "MODIFIED BIODEGRADABLE AND MEDICAL POLYMER DEVICES AND A METHOD FOR PREPARING THE SAME" submitted by Beijing Amet was authorized by the European Patent Office (European Patent Application No. 16900812.5). The application and authorization of this invention patent further demonstrates the confidence and strength of Amet's technological innovation and participation in international competition.

2021

11-16

The project that Beijing Amet participated in won the second prize of the Science and Technology Award of the Chinese Society of Biomaterials

Recently, the "Key Technologies for Design and Manufacture of Biodegradable Implantable Interventional Medical Devices" project, led by Professor Fan Yubo, Dean of the School of Biological and Medical Engineering, Beihang University, and participated by Beijing Natong Medical and Beijing Amat, won the Chinese Society of Biomaterials. Second Prize of Science and Technology Award. At the opening ceremony of the China Biomaterials Conference held at the Shanghai International Convention Center on October 12, 2021, Professor Fan Yubo accepted the award certificate issued by Academician Liu Changsheng on behalf of the Society on behalf of the project team.

2021

10-15

Beijing Amet Biodegradable Peripheral Vascular Drug-Eluting Stent System Approved by NMPA for Registration Clinical Trial Study

Recently, PeriSorb™, a fully degradable peripheral vascular drug-eluting stent system independently developed by Beijing Amet, has been approved to carry out registration clinical trials after the review and approval of the Medical Device Technology Review Center of the National Medical Products Administration (NMPA). https://www.cmde.org.cn/CL0191/23968.html?WxUg5ztDmi=1629961936649). This clinical trial will be launched in a number of tertiary hospitals across the country in the near future. This is the second fully degradable drug-eluting stent to enter clinical research after the company's fully degradable coronary drug-eluting stent (AMSorb®) launched a large-scale randomized controlled clinical trial.

2021

08-26

Two invention patent applications of Beijing Amet were authorized by the State Intellectual Property Office

Recently, the Chinese invention patent applications "A Personalized Polymer Stent and its Preparation Method and Use" and "Modified Biodegradable Medical Polymer Device and Its Preparation Method" submitted by Beijing Amet won the national intellectual property rights. Office of Patent Licensing. So far, Beijing Amet has 9 invention patents authorized by China and the United States.

2021

08-26

Beijing Amet's high-pressure balloon dilatation catheter product was successfully approved for launch

This high-pressure balloon dilatation catheter from Beijing Amet is suitable for dilating coronary stenotic lesions or bypass stenotic lesions to improve myocardial blood supply; it is suitable for post-implantation expansion of coronary stents. It has excellent product properties, including: excellent shape retention ability under high pressure; excellent "wing" embracing performance, which is conducive to product retraction and secondary entry into the guide tube; hydrophilic coating for durable lubrication effect , can withstand up to 25 rubs. In addition, the product has complete specifications and models and a wide coverage, which can fully meet different clinical needs.

2021

07-16

< 1234 > proceed page

Company Information

Beijing Advanced Medical Technologies, Inc.

Contact Us

Address: Building 11, Zhongguancun Medical Equipment Park, No. 26, Yongwang West Road, Daxing District, Beijing

Tel：010-6297-7955           E-Mail：amt@ametcorp.com

Picture Name

WeChat Contact

@Copyright 2022 Beijing Advanced Medical Technologies, Inc. All rights reserved

京ICP备11028039号   Powered by: www.300.cn   SEO